Chinese startup NERVTEX's MoDAS (Movement Dysfunction Assessment Software) system, which is a First-in-Class Artificial ...
CARsgen Therapeutics Holdings, a biopharmaceutical startup based in the US and China, has announced collaboration agreem...
South Korea's Daewoong Pharmaceutical has secured an exclusive licensing agreement with CS Pharmaceuticals, a UK based m...
Shanghai Duoning Biotechnology Co. has signed an agreement on the Transfer of the Right to Use State-owned Construc...
PanopticAI, Hong Kong's leading health and wellness monitoring startup, has announced a deal closing on a seed...
GenScript ProBio, a subsidiary of GenScript Biotech Corporation, has announced its Series C round of financing of n...
ReLive Biotechnologies, founded in 2021, has completed the acquisition of all operating assets of Germany-listed bi...
Hong Kong Science and Technology Parks (HKSTP) Corporation has announced a strategic collaboration with Roche, one of th...
Japan-based Chiome Bioscience has agreed to terminate the License Agreement for anti-TROP-2 antibody ( LIV-20...
Asieris Pharmaceuticals, a China-based biopharma company specialising in discovering, developing and commercialising inn...
The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine), Microbiota I-Center (MagIC), and Hong Kong...
Amcor, a Switzerland-headquartered firm that develops and produces responsible packaging solutions, has entered into an ...
Japan headquatered Takeda's EXKIVITY (mobocertinib) has been approved by the National Medical Products Administration (N...
Primary brain cancer, though not a common malignancy, has a very poor survival rate compared to other types of cancer; m...
Aurisco, an innovative pharmaceutical company and CDMO (contract development and manufacturing organisation) in China, i...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO), has...
China-based Pulnovo Medical has announced the appointment of Dr Mingdong Zhang to the company's Scientific Advisory...
WuXi STA, a subsidiary of WuXi AppTec, has announced that its first drug product Continuous Manufacturing (CM) line for ...
